Cleared Special

K192595 - ExSpiron 2Xi (FDA 510(k) Clearance)

Dec 2019
Decision
88d
Days
Class 2
Risk

K192595 is an FDA 510(k) clearance for the ExSpiron 2Xi. This device is classified as a Spirometer, Monitoring (w/wo Alarm) (Class II - Special Controls, product code BZK).

Submitted by Respiratory Motion (Watertown, US). The FDA issued a Cleared decision on December 17, 2019, 88 days after receiving the submission on September 20, 2019.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.1850.

Submission Details

510(k) Number K192595 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2019
Decision Date December 17, 2019
Days to Decision 88 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code BZK - Spirometer, Monitoring (w/wo Alarm)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.1850